Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Gtpl1152
2. Schembl3041046
Molecular Weight | 3326.8 g/mol |
---|---|
Molecular Formula | C147H237N43O43S |
XLogP3 | -15.9 |
Hydrogen Bond Donor Count | 51 |
Hydrogen Bond Acceptor Count | 51 |
Rotatable Bond Count | 115 |
Exact Mass | 3325.7434694 g/mol |
Monoisotopic Mass | 3324.7401145 g/mol |
Topological Polar Surface Area | 1470 Ų |
Heavy Atom Count | 234 |
Formal Charge | 0 |
Complexity | 7580 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 31 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Vasoactive Intestinal Peptide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vasoactive Intestinal Peptide, including repackagers and relabelers. The FDA regulates Vasoactive Intestinal Peptide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vasoactive Intestinal Peptide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Vasoactive Intestinal Peptide supplier is an individual or a company that provides Vasoactive Intestinal Peptide active pharmaceutical ingredient (API) or Vasoactive Intestinal Peptide finished formulations upon request. The Vasoactive Intestinal Peptide suppliers may include Vasoactive Intestinal Peptide API manufacturers, exporters, distributors and traders.
click here to find a list of Vasoactive Intestinal Peptide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Vasoactive Intestinal Peptide DMF (Drug Master File) is a document detailing the whole manufacturing process of Vasoactive Intestinal Peptide active pharmaceutical ingredient (API) in detail. Different forms of Vasoactive Intestinal Peptide DMFs exist exist since differing nations have different regulations, such as Vasoactive Intestinal Peptide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Vasoactive Intestinal Peptide DMF submitted to regulatory agencies in the US is known as a USDMF. Vasoactive Intestinal Peptide USDMF includes data on Vasoactive Intestinal Peptide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Vasoactive Intestinal Peptide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Vasoactive Intestinal Peptide suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Vasoactive Intestinal Peptide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Vasoactive Intestinal Peptide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Vasoactive Intestinal Peptide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Vasoactive Intestinal Peptide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Vasoactive Intestinal Peptide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Vasoactive Intestinal Peptide suppliers with NDC on PharmaCompass.
Vasoactive Intestinal Peptide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vasoactive Intestinal Peptide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vasoactive Intestinal Peptide GMP manufacturer or Vasoactive Intestinal Peptide GMP API supplier for your needs.
A Vasoactive Intestinal Peptide CoA (Certificate of Analysis) is a formal document that attests to Vasoactive Intestinal Peptide's compliance with Vasoactive Intestinal Peptide specifications and serves as a tool for batch-level quality control.
Vasoactive Intestinal Peptide CoA mostly includes findings from lab analyses of a specific batch. For each Vasoactive Intestinal Peptide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vasoactive Intestinal Peptide may be tested according to a variety of international standards, such as European Pharmacopoeia (Vasoactive Intestinal Peptide EP), Vasoactive Intestinal Peptide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vasoactive Intestinal Peptide USP).
LOOKING FOR A SUPPLIER?